Replies to post #76360 on Biotech Values

[tony111]

But the market cap of ITMN is relative high due to FDA approval expectation do you think people will be willing to invest in the company risking a FDA CR letter?

[drbio45]

vrus is the pure play hep c play

intermune could get some kind of negative news on the ipf product.